EIF2C2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.176000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.111000E-01
Normal-vs-Stage2
3.711000E-01
Normal-vs-Stage3
9.300000E-01
Normal-vs-Stage4
3.063800E-01
Stage1-vs-Stage2
6.999200E-03
Stage1-vs-Stage3
9.625400E-01
Stage1-vs-Stage4
2.993000E-01
Stage2-vs-Stage3
3.363200E-01
Stage2-vs-Stage4
6.614200E-01
Stage3-vs-Stage4
2.963000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.338800E-01
Normal-vs-AfricanAmerican
3.572400E-01
Normal-vs-Asian
4.282200E-01
Caucasian-vs-AfricanAmerican
9.478800E-01
Caucasian-vs-Asian
5.835800E-01
AfricanAmerican-vs-Asian
5.705400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.956200E-01
Normal-vs-Female
4.483400E-01
Male-vs-Female
9.338800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.207800E-01
Normal-vs-Age(41-60Yrs)
2.873600E-01
Normal-vs-Age(61-80Yrs)
4.868600E-01
Normal-vs-Age(81-100Yrs)
5.363800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.694400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.487200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.030200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.022300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.949230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.384400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.937200E-01
Normal-vs-Daily Drinker
5.240200E-01
Normal-vs-Weekly Drinker
3.416600E-01
Normal-vs-Occasional Drinker
2.034000E-01
Normal-vs-Social Drinker
4.526600E-01
Non Drinker-vs-Daily Drinker
6.449600E-01
Non Drinker-vs-Weekly Drinker
7.656600E-01
Non Drinker-vs-Occasional Drinker
4.455600E-01
Non Drinker-vs-Social Drinker
6.008000E-01
Daily Drinker-vs-Weekly Drinker
3.679200E-01
Daily Drinker-vs-Occasional Drinker
1.210810E-01
Daily Drinker-vs-Social Drinker
9.437000E-01
Weekly Drinker-vs-Occasional Drinker
6.350200E-01
Weekly Drinker-vs-Social Drinker
3.487400E-01
Occasional Drinker-vs-Social Drinker
1.220640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.438400E-01
Normal-vs-Grade 2
2.398400E-01
Normal-vs-Grade 3
2.309200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.267200E-01
Grade 1-vs-Grade 3
3.587800E-02
Grade 1-vs-Grade 4
4.438400E-01
Grade 2-vs-Grade 3
1.044440E-01
Grade 2-vs-Grade 4
2.398400E-01
Grade 3-vs-Grade 4
2.309200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.077400E-01
Normal-vs-NonDiabetic
4.429800E-01
Diabetic-vs-NonDiabetic
4.016800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.865900E-02
Normal-vs-NoPancreatitis
4.723200E-01
Pancreatitis-vs-NoPancreatitis
3.252400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.815800E-01
Normal-vs-N1
3.786800E-01
N0-vs-N1
1.280450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.067600E-01
Normal-vs-TP53-NonMutant
8.784400E-01
TP53-Mutant-vs-TP53-NonMutant
2.09079999999862E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
